Precision BioSciences raises $110M to advance genome editing
Durham-based genome editing company Precision BioSciences has raised $110 million to further the development of its proprietary ARCUS genome editing platform.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
